These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 16873279)

  • 1. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection.
    Guadalupe M; Sankaran S; George MD; Reay E; Verhoeven D; Shacklett BL; Flamm J; Wegelin J; Prindiville T; Dandekar S
    J Virol; 2006 Aug; 80(16):8236-47. PubMed ID: 16873279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
    Guadalupe M; Reay E; Sankaran S; Prindiville T; Flamm J; McNeil A; Dandekar S
    J Virol; 2003 Nov; 77(21):11708-17. PubMed ID: 14557656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration.
    George MD; Reay E; Sankaran S; Dandekar S
    J Virol; 2005 Mar; 79(5):2709-19. PubMed ID: 15708990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral therapy during primary simian immunodeficiency virus infection fails to prevent acute loss of CD4+ T cells in gut mucosa but enhances their rapid restoration through central memory T cells.
    Verhoeven D; Sankaran S; Silvey M; Dandekar S
    J Virol; 2008 Apr; 82(8):4016-27. PubMed ID: 18272585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors.
    Sankaran S; Guadalupe M; Reay E; George MD; Flamm J; Prindiville T; Dandekar S
    Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9860-5. PubMed ID: 15980151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection.
    Mehandru S; Poles MA; Tenner-Racz K; Jean-Pierre P; Manuelli V; Lopez P; Shet A; Low A; Mohri H; Boden D; Racz P; Markowitz M
    PLoS Med; 2006 Dec; 3(12):e484. PubMed ID: 17147468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of HIV in the gastrointestinal tract.
    Dandekar S
    Curr HIV/AIDS Rep; 2007 Feb; 4(1):10-5. PubMed ID: 17338855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection.
    Shacklett BL; Cox CA; Sandberg JK; Stollman NH; Jacobson MA; Nixon DF
    J Virol; 2003 May; 77(10):5621-31. PubMed ID: 12719554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired CD4+ T-cell restoration in the small versus large intestine of HIV-1-positive South Africans receiving combination antiretroviral therapy.
    Cassol E; Malfeld S; Mahasha P; Bond R; Slavik T; Seebregts C; Poli G; Cassol S; van der Merwe SW; Rossouw T
    J Infect Dis; 2013 Oct; 208(7):1113-22. PubMed ID: 23749968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up.
    Carsenti-Dellamonica H; Saïdi H; Ticchioni M; Guillouet de Salvador F; Dufayard Cottalorda J; Garraffo R; Dellamonica P; Durant J; Gougeon ML
    HIV Med; 2011 Feb; 12(2):65-77. PubMed ID: 20500532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
    Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A
    Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
    J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status.
    Critchfield JW; Young DH; Hayes TL; Braun JV; Garcia JC; Pollard RB; Shacklett BL
    PLoS One; 2008; 3(10):e3577. PubMed ID: 18974782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunologic aspects of human immunodeficiency virus infection in the gastrointestinal tract.
    Schneider T; Ullrich R; Zeitz M
    Semin Gastrointest Dis; 1996 Jan; 7(1):19-29. PubMed ID: 8903576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses.
    Macal M; Sankaran S; Chun TW; Reay E; Flamm J; Prindiville TJ; Dandekar S
    Mucosal Immunol; 2008 Nov; 1(6):475-88. PubMed ID: 19079215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of gut mucosa and mesenteric lymph nodes in simian immunodeficiency virus-infected macaques with divergent disease course.
    George MD; Verhoeven D; McBride Z; Dandekar S
    J Med Primatol; 2006 Aug; 35(4-5):261-9. PubMed ID: 16872289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
    Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
    J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell responses to highly active antiretroviral therapy defined by chemokine receptors expression, cytokine production, T cell receptor repertoire and anti-HIV T-lymphocyte activity.
    Giovannetti A; Pierdominici M; Mazzetta F; Salemi S; Marziali M; Kuonen D; Iebba F; Lusi EA; Cossarizza A; Aiuti F
    Clin Exp Immunol; 2001 Apr; 124(1):21-31. PubMed ID: 11359439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.